Valdas Pečeliūnas

Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study

Kazimieras Maneikis, Karolis Šablauskas, Ugnė Ringelevičiūtė et al. · The Lancet Haematology · 2021 · 245 citations · Full text

Veterinary Medicine, Hematology, Immunology +15

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Mohamad Mohty, Evangelos Terpos, María‐Victoria Mateos et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 89 citations · Full text

Medicine, Hematology, Pharmacoeconomics +14

Anti-α4β7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease

Ivetta Danylesko, Adomas Bukauskas, Martin Paulson et al. · Bone Marrow Transplantation · 2018 · 53 citations

Life Sciences, Pharmacotherapy, Surgery +12

Circulating plasma cells predict the outcome of relapsed or refractory multiple myeloma

Valdas Pečeliūnas, Aušra Janiulionienė, Rėda Matuzevičienė et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 42 citations

Medicine, Hematology, Oncology +13

Six color flow cytometry detects plasma cells expressing aberrant immunophenotype in bone marrow of healthy donors

Valdas Pečeliūnas, Aušra Janiulionienė, Rėda Matuzevičienė et al. · Cytometry Part B Clinical Cytometry · 2011 · 35 citations · Full text

Medicine, Hematology, Pathology +16